Seizure Disorder Classification
Seizure disorders are fundamentally classified into two major categories: provoked (acute symptomatic) seizures occurring within 7 days of an acute insult, and unprovoked seizures occurring without acute precipitating factors, with epilepsy defined as recurrent unprovoked seizures. 1, 2
Primary Classification Framework
The classification system operates on multiple levels that guide diagnosis, treatment decisions, and prognosis:
Provoked vs. Unprovoked Seizures
Provoked seizures occur at the time of or within 7 days of an acute neurologic, systemic, metabolic, or toxic insult 1, 2
Common provoking factors include:
- Metabolic derangements: hyperglycemia, hyponatremia, hypocalcemia, hypomagnesemia, and uremia 1
- Toxic ingestions: cocaine (causing seizures in ~10% of cocaine-related admissions), tricyclic antidepressants, antihistamines, and theophylline 1
- Alcohol withdrawal (though other symptomatic causes must be eliminated first) 1
- Acute CNS infections: meningitis and encephalitis requiring urgent intervention 1
- Acute structural lesions: intracranial hemorrhage, subdural hematomas, traumatic brain injury 1
Unprovoked seizures occur without acute precipitating factors and are subdivided into: 1, 2
Seizure Type Classification
Beyond the provoked/unprovoked distinction, seizures are classified by their onset pattern:
Generalized seizures: engage bilateral networks from onset, classified by motor manifestations including tonic-clonic, absence, myoclonic, clonic, tonic, and atonic types 3, 4
Classification by Underlying Etiology in Specific Populations
Head Trauma
- Immediate seizures (within 7 days): classified as provoked seizures 1
- Remote traumatic brain injury (>7 days): causes unprovoked seizures and increases epilepsy risk 1
Stroke
- Acute stroke (within 7 days): seizures are provoked 1
- Prior stroke (>7 days before seizure): causes unprovoked seizures, with incidence increasing with age 1
Genetic Predisposition
- Classified as idiopathic generalized epilepsy syndromes including juvenile myoclonic epilepsy, juvenile absence epilepsy, childhood absence epilepsy, or epilepsy with grand mal seizures on awakening 5
Special Populations Requiring Modified Classification
- HIV patients: new-onset seizures require consideration of CNS toxoplasmosis, lymphoma, cryptococcal meningitis, and HIV encephalopathy 1
- Immunocompromised patients: higher rates of infectious etiologies 1
- Neonates: hypoxic ischemic injury (46-65% of cases), intracranial hemorrhage, and perinatal ischemic stroke (10-12%), with ~95% having identifiable underlying causes 1
Critical Diagnostic Distinctions
Key Clinical Predictors
- Focal neurologic examination findings have 97% correlation with symptomatic (provoked) seizures 1
- Fever warrants strong consideration of CNS infection 1
- History and physical examination predict most metabolic abnormalities except occasional hypoglycemia and subdural hematomas 1
Epilepsy Syndrome Classification
Epilepsy (recurrent unprovoked seizures) is further classified into syndromes based on: 2, 6
- Idiopathic: genetic predisposition, no structural abnormality 3, 6
- Symptomatic: known structural or metabolic cause 3, 6
- Cryptogenic: presumed symptomatic but cause unidentified 3, 6
Treatment Implications of Classification
- Provoked seizures: treat the underlying cause rather than initiating long-term antiseizure medications 2
- Unprovoked seizures: antiepileptic drug therapy indicated for recurrent seizures or single seizure with high recurrence risk (prior brain insult, epileptiform EEG abnormalities, structural lesion on neuroimaging) 2
- Status epilepticus: seizures lasting >5 minutes or recurrent seizures without return to baseline, requiring immediate benzodiazepine treatment with mortality of 5-22% 2
Common Pitfalls
- Labeling alcohol withdrawal seizures without eliminating other symptomatic causes first 1
- Missing metabolic abnormalities: approximately 8% of first seizure patients have correctable metabolic causes requiring comprehensive metabolic panel, complete blood count, and toxicology screening 1, 2
- Failing to obtain emergent neuroimaging in patients with persistent focal deficits or failure to return to baseline within several hours 1